{'fraction_non_alphanumeric': 0.025179856115107913, 'fraction_numerical': 0.005995203836930456, 'mean_word_length': 5.185185185185185, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Oral ganciclovir effective for CMV.


 A study published in the journal, AIDS, reveals that ganciclovir capsules (oral Cytovene) are a safe and effective alternative to the intravenous (IV) formulation of the drug for maintenance treatment of cytomegalovirus (CMV) retinitis. The 20-week randomized trial of 159 HIV-infected patients also showed that the oral therapy greatly reduces incidences of sepsis, and catheter-related complications. This oral formulation is helpful to individuals with AIDS who suffer from CMV retinitis because it eliminates daily infusions via a catheter implanted in the chest. The maker of ganciclovir, Syntex, recently announced that it has submitted an application to the Food and Drug Administration (FDA) to market oral ganciclovir to prevent CMV in people at high risk for developing the condition.
